ANS is committed to advancing, fostering, and promoting the development and application of nuclear sciences and technologies to benefit society.
Explore the many uses for nuclear science and its impact on energy, the environment, healthcare, food, and more.
Explore membership for yourself or for your organization.
Conference Spotlight
2026 ANS Annual Conference
May 31–June 3, 2026
Denver, CO|Sheraton Denver
Latest Magazine Issues
Feb 2026
Jul 2025
Latest Journal Issues
Nuclear Science and Engineering
February 2026
Nuclear Technology
January 2026
Fusion Science and Technology
Latest News
Playing the “bad guy” to enhance next-generation safety
Sometimes, cops and robbers is more than just a kid’s game. At the Department of Energy’s national laboratories, researchers are channeling their inner saboteurs to discover vulnerabilities in next-generation nuclear reactors, making sure that they’re as safe as possible before they’re even constructed.
Marta Velarde, Jose Manuel Perlado
Fusion Science and Technology | Volume 43 | Number 3 | May 2003 | Pages 484-491
Technical Paper | Safety and Environment | doi.org/10.13182/FST03-A295
Articles are hosted by Taylor and Francis Online.
The evaluation of the radiological environmental impact of tritium emission to the atmosphere from inertial fusion energy (IFE) reactors has different chronological phases. In the release primary phase, the important factors are the boundary conditions: atmospheric and geometric grid from the point of emission. The second phase occurs when the tritium is deposited in the ground. This phase is important in order to account for the dosimetric effects of tritium, and it is a key factor in the chronic and collective doses of the population.The final internal irradiation dose is calculated as the addition of doses by ingestion, by inhalation of the primary plume, by absorption on the skin, and inhalation by reemission to the atmosphere.Each of the two chemical forms (HT and HTO) of tritium present in the environment from potential IFE reactor releases contributes in different ways to the most exposed individual and the committed effective dose equivalent (50-CEDE). The HTO presents a much larger percentage of the internal irradiation from inhalation and absorption through the skin than HT. However, in releases where HT represents 100%, the contributions to the total effective dose by ingestion and reemission are important.